Ultrasound could one day play a key role in drug delivery, if researchers can harness the ultrasound beam's cavitation effect, which allows drugs to pass through the protective membranes of cells.
Ultrasound could one day play a key role in drug delivery, if researchers can harness the ultrasound beam's cavitation effect, which allows drugs to pass through the protective membranes of cells.
Mark R. Prausnitz, Ph.D., of Georgia Institute of Technology's School of Chemical and Biomolecular Engineering experimented with living prostate cancer and animal cells. He confirmed that the powerful cavitation effect produces enough force to stimulate cell membrane permeability. The holes close down quickly but allow the entry of therapeutic molecules that are 50 nm in diameter, larger than most compounds used for gene therapy (J Ultras Med Bio 2006:32[6]915-924).
The procedure could find future use in systemic therapy in oncology, particularly for large-molecule drugs that cannot easily move through cell membranes.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.